Publications

Publications keep interested parties informed about the latest scientific, clinical, trial-based, and peer-reviewed documentation about our products and pipeline. Find the latest below:

sort by:

Ther. Deliv.

2013; 4(8): 939-49

Device factors affecting pulmonary delivery of dry powders.

view publication

Diabetes Technol. Ther.

2012;14: 9‍97-1‍001

Technosphere Insulin Effectively Controls Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus.

view publication

Diabetes Obesity Metab.

2012; 14: 163-173.

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: A randomized trial.

view publication

Pharm. Res.

2011; 28; 2‍157–2‍164

Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration

view publication

Mol. Pharmaceutics.

2008; 5(2): 294–315

A Delineation of Diketopiperazine Self-Assembly Processes: Understanding the Molecular Events Involved in Nϵ-(Fumaroyl) diketopiperazine of l-Lys (FDKP) Interactions.

view publication

Diabetes Care

2007; 30(9):2307-8

Coverage of Postprandial Blood Glucose Excursions With Inhaled Technosphere Insulin in Comparison to Subcutaneously Injected Regular Human Insulin in Subjects With Type 2 Diabetes.

view publication

Diabetes Technol. Ther.

2007; 9 Suppl 1: S65-72

Technosphere insulin technology.

view publication

Expert Opinion Drug Delivery.

2005; 2(6): 1097-106.

Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.

view publication

Diabetes Technol. Ther.

2002; 4(5): 589-94

Technosphere/Insulin – a New Approach for Effective Delivery of Human Insulin via the Pulmonary Route

view publication

Exp. Clin. Endocrinol. Diabetes

2002; 110(1): 17-21

Technosphere/Insulin–proof of concept study with a new insulin formulation for pulmonary delivery.

view publication
<